Genetic variation at the CYP19A1 locus predicts circulating estrogen levels but not breast cancer risk in postmenopausal women.
The CYP19A1 gene encodes the enzyme aromatase, which is responsible for the final step in the biosynthesis of estrogens. In this study, we used a systematic two-step approach that included gene resequencing and a haplotype-based analysis to comprehensively survey common genetic variation across the...
Main Authors: | Haiman, C, Dossus, L, Setiawan, V, Stram, DO, Dunning, A, Thomas, G, Thun, M, Albanes, D, Altshuler, D, Ardanaz, E, Boeing, H, Buring, J, Burtt, N, Calle, E, Chanock, S, Clavel-Chapelon, F, Colditz, G, Cox, D, Feigelson, H, Hankinson, SE, Hayes, R, Henderson, B, Hirschhorn, J, Hoover, R, Hunter, D |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2007
|
Similar Items
-
Haplotypes of the estrogen receptor beta gene and breast cancer risk.
by: Cox, D, et al.
Published: (2008) -
CYP17 genetic variation and risk of breast and prostate cancer from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).
by: Setiawan, V, et al.
Published: (2007) -
A comprehensive analysis of the androgen receptor gene and risk of breast cancer: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).
by: Cox, D, et al.
Published: (2006) -
A common 8q24 variant in prostate and breast cancer from a large nested case-control study.
by: Schumacher, F, et al.
Published: (2007) -
CYP19A1 genetic variation in relation to prostate cancer risk and circulating sex hormone concentrations in men from the Breast and Prostate Cancer Cohort Consortium.
by: Travis, R, et al.
Published: (2009)